OncoLink at ASCO 2001: Saturday, May 12

OncoLink Booth at ASCO
Managing Editor, Maggie Hampshire, RN, BSN, OCN helps conference goers fill-out the OncoLink/Elsevier Survey.

A Prospective Randomized Trial of Prophylactic Platelet Transfusion and Bleeding Incidence in Hematopoietic Stem Cell Transplant (HSCT) Recipients: 10, 000 μL vs. 20,000 μL Threshold A Randomized, Double-blind, Phase III Study Evaluating Fixed Dose, Once-Per-Cycle Pegylated Filgrastim (SD/01) vs Daily Filgrastim to Support Chemotherapy for Breast Cancer A single Dose of Pegylated Filgrastim (SD/01) is as effective as Daily Filgrastim for Hematologic Support of Chemotherapy in Breast Cancer Patients: Results of a Randomized,k Double-Blind, Phase 3 Trial Amifostine (AF) Cytoprotetion (CP) of Escalating Doses of Melphalan (MEL) and Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Final Results of a Phase I & II study An EORTC Randomized Phase III Trial of Three Chemotherapy Regimens in Advanced Non-Small Cell Lung Cancer (NSCLC) ASCO/European Society for Medical Oncology Joint Session Addresses the Clinical and Ethical Implications of the Human Genome Project Cisplatin/Gemcytobine (CG) vs Cisplatin/Gemcytobine/Vinorelbine (CGV) vs Sequential Doublets of Gemcytobine/Vinorelbine Followed by Ifosfamide/Vinorelbine (GV/IV) in Advanced Non-Small Cell Lung Cancer (NSCLC): Results of a Spanish Lung Cancer Group Phase Efficacy of Recombinant Human Keratinocyte Growth Factor (rHuKGF) in Reducing Mucositis in Patients with Hematologic Malignancies Undergoing Autologous Peripheral Blood Progenitor Cell Transplantation (auto-PBPCT) After Radiation-Based Conditioning ? Resu Health outcomes following primary Androgen therapy in a population-based cohort How Much Chemotherapy Are Cancer Patients Receiving at the End of Life? Informed consent to cancer clinical trials Keeping cancer guidelines current: results of a comprehensive prospective literature monitoring strategy Myelodysplastic (MDS) Syndrome and Leukemia After Autotransplantation for Lymphoma: a Multicenter Case-Control Study Non-Adherence with Adjuvant Tamoxifen Therapy in Women with Early Stage Breast Cancer Opening Address: NCI Director Dr. Richard Klausner Welcomes ASCO Members Providing Audiotapes of Primary Adjuvant Treatment Consultations to Women with Breast Cancer: a Multi-Site Randomized Controlled Trial Results of a Spanish Lung Cancer Group Phase III Trial Satisfaction and anxiety are improved with the use of an easy-to-read informed consent document: a randomized multi-group study The Effect of Hospital Volume and Socioeconomic Status on Colostomy Rates for Rectal Cancer The Quality of Non-Cancer Care Delivered to Elderly Breast Cancer Survivors